OPKO Health Cash on Hand 2010-2024 | OPK

OPKO Health cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
OPKO Health Annual Cash on Hand
(Millions of US $)
2023 $96
2022 $153
2021 $135
2020 $72
2019 $85
2018 $96
2017 $91
2016 $169
2015 $194
2014 $97
2013 $186
2012 $27
2011 $72
2010 $18
2009 $43
OPKO Health Quarterly Cash on Hand
(Millions of US $)
2024-03-31 $76
2023-12-31 $96
2023-09-30 $139
2023-06-30 $108
2023-03-31 $111
2022-12-31 $153
2022-09-30 $181
2022-06-30 $210
2022-03-31 $102
2021-12-31 $135
2021-09-30 $149
2021-06-30 $66
2021-03-31 $90
2020-12-31 $72
2020-09-30 $36
2020-06-30 $22
2020-03-31 $35
2019-12-31 $85
2019-09-30 $65
2019-06-30 $111
2019-03-31 $207
2018-12-31 $96
2018-09-30 $44
2018-06-30 $80
2018-03-31 $100
2017-12-31 $91
2017-09-30 $100
2017-06-30 $131
2017-03-31 $131
2016-12-31 $169
2016-09-30 $145
2016-06-30 $172
2016-03-31 $175
2015-12-31 $194
2015-09-30 $212
2015-06-30 $221
2015-03-31 $348
2014-12-31 $97
2014-09-30 $118
2014-06-30 $134
2014-03-31 $156
2013-12-31 $186
2013-09-30 $181
2013-06-30 $169
2013-03-31 $182
2012-12-31 $27
2012-09-30 $42
2012-06-30 $55
2012-03-31 $62
2011-12-31 $72
2011-09-30 $87
2011-06-30 $94
2011-03-31 $108
2010-12-31 $18
2010-09-30 $15
2010-06-30 $20
2010-03-31 $39
2009-12-31 $43
2009-09-30 $63
2009-06-30 $41
2009-03-31 $2
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.878B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $217.261B 26.33
Intuitive Surgical (ISRG) United States $154.295B 92.95
Edwards Lifesciences (EW) United States $53.342B 34.71
DexCom (DXCM) United States $46.386B 70.26
Alcon (ALC) Switzerland $44.049B 31.57
IDEXX Laboratories (IDXX) United States $41.591B 48.75
IQVIA Holdings (IQV) United States $38.778B 22.50
STERIS (STE) Ireland $21.402B 25.00
SONOVA HOLDING (SONVY) Switzerland $18.282B 0.00
Waters (WAT) United States $17.464B 25.67
Hologic (HOLX) United States $16.679B 18.66
Fresenius Medical Care AG KGaA (FMS) Germany $11.531B 13.46
Sysmex ADR (SSMXY) Japan $9.982B 31.30
Teleflex (TFX) United States $9.519B 14.82
Globus Medical (GMED) United States $9.073B 26.59
Masimo (MASI) United States $7.222B 41.53
Penumbra (PEN) United States $6.824B 77.55
Glaukos (GKOS) United States $5.711B 0.00
TransMedics (TMDX) United States $4.808B 456.12
Integer Holdings (ITGR) United States $3.854B 23.28
PROCEPT BioRobotics (PRCT) United States $3.188B 0.00
LivaNova (LIVN) United Kingdom $2.893B 17.18
Tandem Diabetes Care (TNDM) United States $2.766B 0.00
Nihon Kohden (NHNKY) Japan $2.661B 14.09
Inari Medical (NARI) United States $2.641B 0.00
Elekta AB (EKTAY) Sweden $2.365B 18.13
Integra LifeSciences Holdings (IART) United States $2.285B 9.97
RxSight (RXST) United States $2.111B 0.00
Veracyte (VCYT) United States $1.637B 0.00
Alphatec Holdings (ATEC) United States $1.452B 0.00
Silk Road Medical (SILK) United States $1.060B 0.00
Artivion (AORT) United States $0.967B 92.76
AVANOS MEDICAL, INC (AVNS) United States $0.876B 17.05
OrthoPediatrics (KIDS) United States $0.713B 0.00
Pulse Biosciences (PLSE) United States $0.630B 0.00
IRadimed (IRMD) United States $0.536B 30.01
SiBone (SIBN) United States $0.511B 0.00
Mesa Laboratories (MLAB) United States $0.492B 14.60
ORTHOFIX MEDICAL INC (OFIX) United States $0.483B 0.00
Paragon 28 (FNA) United States $0.474B 0.00
Pacific Biosciences Of California (PACB) United States $0.448B 0.00
Treace Medical Concepts (TMCI) United States $0.374B 0.00
Nevro (NVRO) United States $0.324B 0.00
Sight Sciences (SGHT) United States $0.318B 0.00
AxoGen (AXGN) United States $0.312B 0.00
Tactile Systems Technology (TCMD) United States $0.273B 9.34
Semler Scientific (SMLR) United States $0.263B 13.35
CVRx (CVRX) United States $0.239B 0.00
AngioDynamics (ANGO) United States $0.226B 0.00
Delcath Systems (DCTH) United States $0.212B 0.00
EDAP TMS S.A (EDAP) France $0.195B 0.00
908 Devices (MASS) United States $0.189B 0.00
NeuroPace (NPCE) United States $0.187B 0.00
Inogen (INGN) United States $0.180B 0.00
Accuray (ARAY) United States $0.173B 0.00
Alpha Tau Medical (DRTS) Israel $0.155B 0.00
ClearPoint Neuro (CLPT) United States $0.144B 0.00
Atossa Genetics (ATOS) United States $0.141B 0.00
Yubo Biotech (YBGJ) China $0.129B 0.00
KORU Medical Systems (KRMD) United States $0.102B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.085B 17.79
InspireMD (NSPR) Israel $0.068B 0.00
Monogram Orthopaedics (MGRM) United States $0.067B 0.00
EnVVeno Medical (NVNO) United States $0.063B 0.00
Hyperfine (HYPR) United States $0.060B 0.00
SEP Acquisition (SEPA) United States $0.056B 0.00
Neuronetics (STIM) United States $0.055B 0.00
LENSAR (LNSR) United States $0.050B 0.00
Envoy Medical (COCH) United States $0.048B 0.00
T2 Biosystems (TTOO) United States $0.047B 0.00
Lucid Diagnostics (LUCD) United States $0.038B 0.00
ReWalk Robotics (LFWD) Israel $0.036B 0.00
Precision Optics (POCI) United States $0.035B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
Vicarious Surgical (RBOT) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Accelerate Diagnostics (AXDX) United States $0.026B 0.00
Pixie Dust Technologies (PXDT) Japan $0.022B 0.00
Autonomix Medical (AMIX) United States $0.021B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.021B 0.00
Aspira Women's Health (AWH) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Venus Concept (VERO) Canada $0.006B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Avinger (AVGR) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.001B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00